Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

rhuMAb-E25 may be safely administered during a second pollen season

Dec. 1, 1999

1999 ACAAI news: SC-236 modulates histamine release in in vitro model of allergy

Dec. 1, 1999

Dynavax and Stallergenes to develop seasonal allergy therapy

Nov. 29, 1999

Amrad to distribute PathoGenesis's inhalable CF treatment in Australia

Nov. 26, 1999

SB investigates CCR3 receptor blockade as a novel approach to allergic, inflammatory disorders

Nov. 25, 1999

Advair approved in Canada, recommended for approval in U.S.

Nov. 25, 1999

Curosurf approved in U.S. for treatment of RDS in premature infants

Nov. 25, 1999

Sepracor and Abbott to copromote Xopenex in the U.S.

Nov. 22, 1999

Dual NK1/NK2 antagonist examined for disposition in rats

Nov. 22, 1999

RPR's new cell adhesion inhibitors especially useful for asthma, joint inflammation and IBD

Nov. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...